These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25596251)

  • 21. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
    Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
    Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
    Dai DL; Martinka M; Li G
    J Clin Oncol; 2005 Mar; 23(7):1473-82. PubMed ID: 15735123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
    Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of galectin-3 expression with melanoma progression and prognosis.
    Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
    Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.
    Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB
    Oncology; 2014; 86(3):159-69. PubMed ID: 24643220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PUMA expression is significantly reduced in human cutaneous melanomas.
    Karst AM; Dai DL; Martinka M; Li G
    Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of transforming growth factor beta 1 [TGF-β1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma.
    Elahi M; Rakhshan V; Ghasemian NT; Moshref M
    Biomarkers; 2012 Feb; 17(1):21-7. PubMed ID: 22106837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maspin expression in the invasive margin of primary melanomas may reflect an aggressive tumor phenotype.
    Pföhler C; Knöpflen T; Körner R; Vogt T; Rösch A; Müller CS
    J Dtsch Dermatol Ges; 2013 Oct; 11(10):993-9. PubMed ID: 23848940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic study of 85 cases of melanoma of the female genitalia.
    Tcheung WJ; Selim MA; Herndon JE; Abernethy AP; Nelson KC
    J Am Acad Dermatol; 2012 Oct; 67(4):598-605. PubMed ID: 22243767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
    Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
    J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of chemokine receptor CXCR4 expression by transforming growth factor-β1 in human basal cell carcinoma cells.
    Chu CY; Sheen YS; Cha ST; Hu YF; Tan CT; Chiu HC; Chang CC; Chen MW; Kuo ML; Jee SH
    J Dermatol Sci; 2013 Nov; 72(2):123-33. PubMed ID: 23856244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas.
    Kondratiev S; Gnepp DR; Yakirevich E; Sabo E; Annino DJ; Rebeiz E; Laver NV
    Hum Pathol; 2008 Mar; 39(3):337-43. PubMed ID: 18045645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective induction of interleukin-8 expression in metastatic melanoma cells by transforming growth factor-beta 1.
    Liu G; Zhang F; Lee J; Dong Z
    Cytokine; 2005 Aug; 31(3):241-9. PubMed ID: 15975819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics.
    Culhaci N; Sagol O; Karademir S; Astarcioglu H; Astarcioglu I; Soyturk M; Oztop I; Obuz F
    BMC Cancer; 2005 Aug; 5():98. PubMed ID: 16086840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of FHL2 during mineralization of human periodontal ligament cells in vitro].
    Wang L; Ge S; Wang X; Yang P
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Aug; 29(4):344-7. PubMed ID: 21932648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of in situ and plasma levels of transforming growth factor β1, -2 and -3 in cutaneous melanoma.
    Tang MR; Wang YX; Guo S; Han SY; Li HH; Jin SF
    Mol Med Rep; 2015 Jun; 11(6):4508-12. PubMed ID: 25625662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.